2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary

Predictors of ischemic stroke for low-risk patients with atrial fibrillation: A matched case-control study

(2021) Soonil Kwon et al.   HEART RHYTHM

Off-label underdosed apixaban use in Asian patients with non-valvular atrial fibrillation

(2021) So-Ryoung Lee et al.   European Heart Journal-Cardiovascular Pharmacotherapy

Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation

(2021) Tze-Fan Chao et al.   Clinical Research in Cardiology

Body Mass Index and Clinical Outcomes in Asian Patients With Atrial Fibrillation Receiving Oral Anticoagulation

(2021) So-Ryoung Lee et al.   STROKE

Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: is it time to reconsider our therapeutic strategy?

(2021) Panteleimon E Papakonstantinou et al.   European Journal of Preventive Cardiology

Device-Related Thrombus After Left Atrial Appendage Closure: Data on Thrombus Characteristics, Treatment Strategies, and Clinical Outcomes From the EUROC-DRT-Registry

(2021) Alexander Sedaghat et al.   Circulation-Cardiovascular Interventions

Alcohol Abstinence and the Risk of Atrial Fibrillation in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: A Nationwide Population-Based Study

(2021) You-jung Choi et al.   DIABETES CARE

2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

(2021) Jan Steffel et al.   EUROPACE

Incident atrial fibrillation and its risk prediction in patients developing COVID-19: A machine learning based algorithm approach

(2021) Gregory Y.H. Lip et al.   European Journal of Internal Medicine

Association of cardiovascular health and incident atrial fibrillation in elderly population

(2021) Jae-Hyuk Lee et al.   HEART

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit

(2021) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19

(2021) Azita H. Talasaz et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke

(2021) Richard P. Whitlock et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 vaccine and thrombosis: Expert opinions

(2021) Ismail Elalamy et al.   THROMBOSIS AND HAEMOSTASIS

Optimal Management of Anticoagulation Therapy in Asian Patients With Atrial Fibrillation

(2021) Wen-Han Cheng et al.   CIRCULATION JOURNAL

A meta-analysis of clinical risk factors for stroke in anticoagulant-naïve patients with atrial fibrillation

(2021) Jean Jacques Noubiap et al.   EUROPACE

Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study

(2021) So-Ryoung Lee et al.   EUROPEAN HEART JOURNAL

Endotheliopathy Marked by High von Willebrand Factor (vWF) Antigen in COVID-19 is Associated with Poor Outcome: A Systematic Review and Meta-analysis

(2021) Arief Wibowo et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial

(2021) Renato D Lopes et al.   LANCET

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

(2021)   NEW ENGLAND JOURNAL OF MEDICINE

The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper

(2021) Grigoris T. Gerotziafas et al.   THROMBOSIS AND HAEMOSTASIS

Adherence to the ‘Atrial Fibrillation Better Care’ Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes—A Systematic Review and Meta-Analysis of 285,000 Patients

(2021) Giulio Francesco Romiti et al.   THROMBOSIS AND HAEMOSTASIS

Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes

(2021) José Miguel Rivera-Caravaca et al.   THROMBOSIS RESEARCH

Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: A nationwide population-based cohort study

(2021) Hyo-Jeong Ahn et al.   PLOS MEDICINE

Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis

(2021) Giulio Francesco Romiti et al.   Journal of Clinical Medicine

Comparison of HAS-BLED and ORBIT Bleeding Risk Scores in AF Patients treated with NOACs: A Report from the ESC-EHRA EORP-AF General Long-Term Registry

(2021) Marco Proietti et al.   European Heart Journal-Quality of Care and Clinical Outcomes

Quality indicators in the management of elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry

(2021) Yutao Guo et al.   European Heart Journal-Quality of Care and Clinical Outcomes

Targeted atrial fibrillation detection in COVID-19 vaccination clinics

(2021) Gary A Ford et al.   European Heart Journal-Quality of Care and Clinical Outcomes

Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study

(2021) Tze-Fan Chao et al.   European Heart Journal-Quality of Care and Clinical Outcomes

Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therapy control based on an SAMe-TT2R2 score-guided strategy in anticoagulant-naïve Thai patients with atrial fibrillation (TREATS-AF): a study protocol

(2021) Arintaya Phrommintikul et al.   BMJ Open

Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

(2020) Arjun K. Pandey et al.   THROMBOSIS AND HAEMOSTASIS

Should We Adopt a Standard International Normalized Ratio Range of 2.0 to 3.0 for Asian Patients with Atrial Fibrillation? An Appeal for Evidence-Based Management, Not Eminence-Based Recommendations

(2020) Tze-Fan Chao et al.   THROMBOSIS AND HAEMOSTASIS

Risks and Outcomes of Gastrointestinal Malignancies in Anticoagulated Atrial Fibrillation Patients Experiencing Gastrointestinal Bleeding – A Nationwide Cohort Study

(2020) Ting-Yung Chang et al.   HEART RHYTHM

Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation

(2020) Yutao Guo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

(2020) Behnood Bikdeli et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research

(2020) Mahesh V. Madhavan et al.   THROMBOSIS AND HAEMOSTASIS

Incident Comorbidities, Aging and the Risk of Stroke in 608,108 Patients with Atrial Fibrillation: A Nationwide Analysis

(2020) Laurent Fauchier et al.   Journal of Clinical Medicine

Off-label dosing of non–vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation

(2020) Yi-Hsin Chan et al.   HEART RHYTHM

Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation

(2020) Pavel Osmancik et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)

(2020) Gerhard Hindricks et al.   EUROPEAN HEART JOURNAL

Impacts of Different Renal Function Estimation Formulas on Dosing of DOACs and Clinical Outcomes

(2020) Yi-Hsin Chan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19

(2020) Girish N. Nadkarni et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Prognostic Value of Electrocardiogram at Presentation to Emergency Department in Patients With COVID-19

(2020) Pierre Elias et al.   MAYO CLINIC PROCEEDINGS

Long-term PM2.5 exposure and the clinical application of machine learning for predicting incident atrial fibrillation

(2020) In-Soo Kim et al.   Scientific Reports

Evaluation of Remote Pharmacist-Led Outpatient Service for Geriatric Patients on Rivaroxaban for Nonvalvular Atrial Fibrillation During the COVID-19 Pandemic

(2020) Xiaoye Li et al.   Frontiers in Pharmacology

Effect of alcohol consumption on the risk of adverse events in atrial fibrillation: from the COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF) registry

(2020) Chewan Lim et al.   EUROPACE

Reduction in all-cause mortality in COVID-19 patients on chronic oral anticoagulation: A population-based propensity score matched study

(2020) Gentian Denas et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Reassessment of Risk for Stroke During Follow-up of Patients With Atrial Fibrillation

(2019) Tze-Fan Chao et al.   ANNALS OF INTERNAL MEDICINE

Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study

(2019) Jiesuck Park et al.   PLoS One

Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review

(2019) Danai Bem et al.   THROMBOSIS AND HAEMOSTASIS

Recommendations on stroke prevention for patients having a CHA2DS2-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines

(2019) Tze-Fan Chao et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Incident Co-Morbidities in Patients with Atrial Fibrillation Initially with a CHA2DS2-VASc Score of 0 (Males) or 1 (Females): Implications for Reassessment of Stroke Risk in Initially ‘Low-Risk’ Patients

(2019) Tze-Fan Chao et al.   THROMBOSIS AND HAEMOSTASIS

Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function

(2019) So-Ryoung Lee et al.   STROKE

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

(2019) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

(2019) Renato D. Lopes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Body Mass Index Variability and Long-term Risk of New-Onset Atrial Fibrillation in the General Population: A Korean Nationwide Cohort Study

(2019) Yeong-Min Lim et al.   MAYO CLINIC PROCEEDINGS

Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight

(2019) So-Ryoung Lee et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial

(2019) Jonas Oldgren et al.   EUROPEAN HEART JOURNAL

Importance of risk reassessment in patients with atrial fibrillation in guidelines: Assessing risk as a dynamic process

(2019) Ting-Yung Chang et al.   CANADIAN JOURNAL OF CARDIOLOGY

Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology

(2019) Lucas V. Boersma et al.   Circulation-Arrhythmia and Electrophysiology

Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial

(2019) Stefan H Hohnloser et al.   EUROPEAN HEART JOURNAL

Major Adverse Events With Percutaneous Left Atrial Appendage Closure in Patients With Atrial Fibrillation

(2019) Laurent Fauchier et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation

(2019) So-Ryoung Lee et al.   AMERICAN JOURNAL OF CARDIOLOGY

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease

(2019) So-Ryoung Lee et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation

(2019) Wen-Han Cheng et al.   STROKE

Cost‐Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5‐Year, Long‐Term Data

(2019) Vivek Y. Reddy et al.   Journal of the American Heart Association

Efficacy and Safety of Uninterrupted Periprocedural Edoxaban in Patients Undergoing Catheter Ablation for Atrial Fibrillation　― The Prospective KYU-RABLE Study ―

(2019) Naohiko Takahashi et al.   CIRCULATION JOURNAL

EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update

(2019) Michael Glikson et al.   EUROPACE

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial

(2019) Pascal Vranckx et al.   LANCET

Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease

(2019) Satoshi Yasuda et al.   NEW ENGLAND JOURNAL OF MEDICINE

Global Use of Idarucizumab in Clinical Practice: Outcomes of the RE-VECTO Surveillance Program

(2019) John Fanikos et al.   THROMBOSIS AND HAEMOSTASIS

Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis

(2019) Yi-Hsin Chan et al.   CARDIOVASCULAR DRUGS AND THERAPY

The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients

(2019) Daehoon Kim et al.   EUROPACE

Bodyweight fluctuation is associated with increased risk of incident atrial fibrillation

(2019) Hyun-Jung Lee et al.   HEART RHYTHM

Dabigatran Reversal With Idarucizumab in Patients With Renal Impairment

(2019) John W. Eikelboom et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

NOAC Adherence of Patients with Atrial Fibrillation in the Real World: Dosing Frequency Matters?

(2019) Jongmin Hwang et al.   THROMBOSIS AND HAEMOSTASIS

Physical Activity and Risk of Atrial Fibrillation: A Nationwide Cohort Study in General Population

(2019) Moo-Nyun Jin et al.   Scientific Reports

Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation

(2019) Tze-Fan Chao et al.   CHEST

10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population

(2018) Daehoon Kim et al.   AMERICAN HEART JOURNAL

Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation

(2018) Yutao Guo et al.   AMERICAN JOURNAL OF MEDICINE

Lifetime Risks, Projected Numbers, and Adverse Outcomes in Asian Patients With Atrial Fibrillation

(2018) Tze-Fan Chao et al.   CHEST

Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation

(2018) Tze-Fan Chao et al.   CIRCULATION

PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study

(2018) Melissa E Middeldorp et al.   EUROPACE

Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events

(2018) Kohki Nakamura et al.   EUROPACE

Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation

(2018) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

An updated meta-analysis of novel oral anticoagulants versus vitamin K antagonists for uninterrupted anticoagulation in atrial fibrillation catheter ablation

(2018) Rhanderson Cardoso et al.   HEART RHYTHM

A meta-analysis of randomized controlled trials of uninterrupted periprocedural anticoagulation strategy in patients undergoing atrial fibrillation catheter ablation

(2018) Yating Zhao et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Percutaneous Left Atrial Appendage Closure with WATCHMAN™ device: peri-procedural and mid-term outcomes from the TRAPS Registry

(2018) Patrizio Mazzone et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation

(2018) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation

(2018) Laurent Fauchier et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation

(2018) Tae-Hoon Kim et al.   STROKE

Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors

(2018) Tze-Fan Chao et al.   THROMBOSIS AND HAEMOSTASIS

Dynamic Changes of CHA2DS2-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study

(2018) Minjae Yoon et al.   THROMBOSIS AND HAEMOSTASIS

Antithrombotic Therapy for Atrial Fibrillation

(2018) Gregory Y.H. Lip et al.   CHEST

Ideal Blood Pressure in Patients With Atrial Fibrillation

(2018) Daehoon Kim et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan

(2018) Tze-Fan Chao et al.   CIRCULATION

Percutaneous WATCHMAN Left Atrial Appendage Closure for Japanese Patients With Nonvalvular Atrial Fibrillation at Increased Risk of Thromboembolism　― First Results From the SALUTE Trial ―

(2018) Kazutaka Aonuma et al.   CIRCULATION JOURNAL

Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population

(2018) Tae-Hoon Kim et al.   EUROPEAN HEART JOURNAL

When is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation? A multicentre prospective randomized study

(2018) Hee Tae Yu et al.   EUROPEAN HEART JOURNAL

Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities

(2018) Tze-Fan Chao et al.   EUROPEAN HEART JOURNAL

Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial

(2018) Tze-Fan Chao et al.   EUROPEAN HEART JOURNAL

Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials

(2018) Kang-Ling Wang et al.   EUROPEAN HEART JOURNAL

Long-term exposure of fine particulate matter air pollution and incident atrial fibrillation in the general population: A nationwide cohort study

(2018) In-Soo Kim et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review

(2018) Ethan Borre et al.   THROMBOSIS AND HAEMOSTASIS

Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort study in Korea

(2017) Sean S. Lee et al.   EUROPEAN HEART JOURNAL

Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial

(2017) Lucas V. Boersma et al.   HEART RHYTHM

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

(2017) Hugh Calkins et al.   HEART RHYTHM

When Less Is Not More ∗

(2017) Sean D. Pokorney et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction

(2017) Xiaoxi Yao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The ABC pathway: an integrated approach to improve AF management

(2017) Gregory Y. H. Lip   Nature Reviews Cardiology

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

(2017) Christopher P. Cannon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

(2017) Charles V. Pollack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation

(2017) Hugh Calkins et al.   NEW ENGLAND JOURNAL OF MEDICINE

Is There an Obesity Paradox for Outcomes in Atrial Fibrillation?

(2017) Marco Proietti et al.   STROKE

CHA 2 DS 2 -VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke

(2017) Tae-Hoon Kim et al.   STROKE

CHA 2 DS 2 -VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65–74, Female) for Stroke in Asian Patients With Atrial Fibrillation

(2017) Tae-Hoon Kim et al.   STROKE

Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

(2017) Jean Collet et al.   THROMBOSIS AND HAEMOSTASIS

Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

(2016) Dominick J. Angiolillo et al.   Circulation-Cardiovascular Interventions

Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians?

(2016) Tze-Fan Chao et al.   HEART RHYTHM

Relation of the SAMe-TT 2 R 2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials

(2016) Marco Proietti et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Underweight is a risk factor for atrial fibrillation: A nationwide population-based study

(2016) Si-Hyuck Kang et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Association of smoking with the risk of incident atrial fibrillation: A meta-analysis of prospective studies

(2016) Wengen Zhu et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Exercise Capacity and Atrial Fibrillation Risk in Veterans

(2016) Charles Faselis et al.   MAYO CLINIC PROCEEDINGS

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

(2016) C. Michael Gibson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence

(2016) Pak Hei Chan et al.   PLoS One

Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study

(2016) Peter Brønnum Nielsen et al.   Scientific Reports

The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective ‘Real-world’ Inception Cohort Study

(2015) Vanessa Roldán et al.   AMERICAN JOURNAL OF MEDICINE

Target Intensity of Anticoagulation With Warfarin in Japanese Patients With Valvular Atrial Fibrillation

(2015) Eitaro Kodani et al.   CIRCULATION JOURNAL

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation

(2015) Riccardo Cappato et al.   EUROPEAN HEART JOURNAL

The CHADS2 and CHA2DS2-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis

(2015) Qinmei Xiong et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation

(2015) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Time to Cost-Effectiveness Following Stroke Reduction Strategies in AF

(2015) Vivek Y. Reddy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?

(2015) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation

(2015) David R. Holmes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation

(2015) Rajeev K. Pathak et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort

(2015) Rajeev K. Pathak et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Idarucizumab for Dabigatran Reversal

(2015) Charles V. Pollack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity

(2015) Deborah M. Siegal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation

(2015) Kang-Ling Wang et al.   STROKE

SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation

(2014) Pilar Gallego et al.   AMERICAN JOURNAL OF MEDICINE

Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management

(2014) Luigi Di Biase et al.   CIRCULATION

Percutaneous Left Atrial Appendage Occlusion for Stroke Prophylaxis in Nonvalvular Atrial Fibrillation

(2014) Navkaranbir Singh Bajaj et al.   JACC-Cardiovascular Interventions

Alcohol Consumption and Risk of Atrial Fibrillation

(2014) Susanna C. Larsson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation

(2014) Rajeev K. Pathak et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy

(2014) David R. Holmes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Using the CHA2DS2-VASc Score for Refining Stroke Risk Stratification in ‘Low-Risk’ Asian Patients With Atrial Fibrillation

(2014) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Body Mass Index and Adverse Events in Patients with Incident Atrial Fibrillation

(2013) Thure Filskov Overvad et al.   AMERICAN JOURNAL OF MEDICINE

A specific antidote for dabigatran: functional and structural characterization

(2013) F. Schiele et al.   BLOOD

Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin

(2013) Stavros Apostolakis et al.   CHEST

Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature

(2013) Stefan H. Hohnloser et al.   EUROPACE

Alcohol intake and prognosis of atrial fibrillation

(2013) Thure Filskov Overvad et al.   HEART

Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation

(2013) Hany S. Abed et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

(2013) Willem JM Dewilde et al.   LANCET

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa

(2013) Genmin Lu et al.   NATURE MEDICINE

A randomized study of the effects of exercise training on patients with atrial fibrillation

(2011) Philip Samuel Osbak et al.   AMERICAN HEART JOURNAL

Safety of Percutaneous Left Atrial Appendage Closure

(2011) Vivek Y. Reddy et al.   CIRCULATION

Smoking and incidence of atrial fibrillation: Results from the Atherosclerosis Risk in Communities (ARIC) Study

(2011) Alanna M. Chamberlain et al.   HEART RHYTHM

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis

(2009) J. Abdulla et al.   EUROPACE

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

(2009) David R Holmes et al.   LANCET

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Physical Activity and Incidence of Atrial Fibrillation in Older Adults

(2008) Dariush Mozaffarian et al.   CIRCULATION

Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation

(2008) Yi Wan et al.